Learning Objectives: Upon finishing this course, the participants will be able to
A. Differentiate the mimickers of bladder neoplasia.
B. Review the strategies and useful tips for grading prostatic cancers.
C. Accurately differentiate the urologic tumors using molecular tests.
D. Recognize the latest urologic oncology technology.
Target Audience: Pathologists, Physicians, Surgeons and other Allied Health Professionals
Course Faculty
Handouts (password protected, only accessible to the meeting attendees)
How to download? Click the links below, and the download will start immediately. OR you may hover your mouse over the link, right click the mouse, and then choose “save as” to save the file to the location of your desire.
The file sizes are large. Caution should be used while downloading with your wireless/mobile devices and their data plan.
Part I , size 15.5M
Part II, size 16M
Date: Sunday April 15, 2018.
Registration and lunch are complimentary.
RSVP before Thur. March 15, 2018 at https://tinyurl.com/5thpips
Location: Meeting Rooms C, D& E, First Floor Education Building, PHCS (see Venue and Directions).
8:25- 8:30 am Opening Remarks by the Program Directors: Lanjing “L.J.” Zhang, MD, PMC/Rutgers University and Jiaoti Huang, MD, PhD, Duke University
8:30-9:15 am Grading of prostate cancer from Gleason to a new patient-centric grading system. by Dr. Jonathan Epstein, Johns Hopkins University
9:15-9:45 am Intraoperative molecular imaging for GU cancer surgery by Dr. Thomas Guzzo, University of Pennsylvania
Morning break 9:45-10:00 am
10:00-10:45 am Mimickers of bladder neoplasia. by Dr. Jonathan Epstein, Johns Hopkins University
10:45-11:30 am Application and pitfalls of immunochemistry for urologic pathology. by Dr. Ximing Yang, Northwestern University
11:30-12:15 pm Challenging cases in genitourinary pathology. by Dr. Chin-Lee Wu, MGH/Harvard University
Lunch break 12:15-1:15 pm
12:30-1:15 pm Grading of GU tumors: an interactive exercise (NON-CME activity). by Dr. Chin-Lee Wu, MGH/Harvard University
1:15-2:00 pm Practical applications of molecular testing in urologic pathology. by Dr. Liang Cheng, Indiana University
2:00-2:45 pm Diagnostic dilemmas in the morphologic evaluation of renal neoplasm. by Dr. Victor Reuter, Memorial Sloan Kettering Cancer Center
2:45-3:30 pm Deceptively benign-appearing prostate cancers. by Dr. Peter Humphrey, Yale University
3:30-5:00 pm Networking session
Princeton HealthCare System is accredited by the Medical Society of New Jersey to provide continuing medical education for physicians. Princeton HealthCare System designates this live activity for a maximum of five point seventy five (5.75) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
If you have a disability that may require special assistance, please contact Janis Puleio, CME Coordinator at (609) 853-7450.
Sponsors (alphabetical order)
Aurora Diagnostics
Foundation Medicine
Neogenomics
New Jersey Institute of Medicine
Princeton Medical Center